A Drivsholm

In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients

Christian H. Geisler, Preben Philip, B. Egelund Christensen et al. · Leukemia Research · 1997 · 113 citations

Life Sciences, Genetics, Hematology +13

Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.

Hansen Op, J Pedersen-Bjergaard, J Ellegaard et al. · PubMed · 1991 · 71 citations

Medicine, Hematology, Oncology +15

Effect of Various Doses of Intravenous Polyclonal IgG on in vivo Levels of 12 Pneumococcal Antibodies in Patients with Chronic Lymphocytic Leukaemia and Multiple Myeloma

I. Sklenar, Gerald Schiffman, Viggo Jønsson et al. · Oncology · 2009 · 41 citations

Pharmacy, Hematology, Immunology +16

Long‐term Treatment with Corticosteroids in Rheumatoid Arthritis: (Over a Period of 9 to 12 Years)

Janni Nielsen, A Drivsholm, FJ Fischer et al. · Acta Medica Scandinavica · 1963 · 37 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.

J Pedersen-Bjergaard, H Brincker, J Ellegaard et al. · PubMed · 1984 · 33 citations

Medicine, Oncology, Pharmacotherapy +17